MTB-22252

N/A

Report date: 2025/06/11 11:14:42
NME

Base Information

Drug NameMTB-22252
Drug Alias Namefatty acid-binding protein 5 inhibitors (Metabomeds)MTB-22252MTB-2252
ClassificationSmall molecules
Mechanisms of ActionFatty acid binding protein 5 inhibitors
TargetsFatty acid binding protein 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetaboMed Inc
China Registration ClassN/A

Develop Information

Active CompaniesMetaboMed Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A